Thyroid Cancer Presenting as an Incidentaloma Detected on F-18 FDG PET/CT Imaging: A Case Report

Authors

  • Jiraporn Sriprapaporn Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Boonsiri Srisuwan Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Mongkol Uiprasertkul Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Pongpija Tuchinda Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Thonnapong Thongpraparn Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700
  • Chompunoot Hannanthawiwat Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700

Keywords:

PET/CT; incidentaloma; thyroid cancer

Abstract

The authors report a woman with a history of malignant B-cell lymphoma (MALT lymphoma) at the lower lobe of
the left lung status post left lower lobe lobectomy who underwent F-18 FDG PET/CT whole-body imaging for evaluation of
any suspicious new pulmonary lesion. The study incidentally found abnormal focal hypermetabolic activity, called incidentaloma,
at the right thyroid lobe, which was pathologically proven to be papillary thyroid carcinoma. She was further treated
with radioiodine therapy after a total thyroidectomy had been done.

References

1. Fletcher JW, Djulbegovic B, Soares H, Siegel BA, Lowe VJ, Lyman
GH, et al. Recommendations on the use of F18-FDG PET in oncology.
J Nucl Med. 2008 Mar;49(3):480-508.
2. Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.
PET/CT for the staging and follow-up of patients with malignancies. Eur
J Radiol. 2009 Jun;70(3):382-92.
3. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary
malignancies with PET/CT. J Nucl Med. 2005 May;46(5):752-7.
4. Liu Y, Ghesani NV, Zuckier LS. Physiology and pathophysiology of
incidental findings detected on FDG-PET scintigraphy. Semin Nucl Med.
2010 Jul;40(4):294-315.
5. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM,
Nathan MA, et al. Clinical significance of diffusely increased 18F-FDG
uptake in the thyroid gland. J Nucl Med. 2007 Jun;48(6):896-901.
6. Liu Y. Clinical significance of thyroid uptake on F 18-fluorodeoxyglucose
positron emission tomography. Ann Nucl Med. 2009 Jan;23(1):17-23.
7. Chen YK, Chen YL, Cheng RH, Yeh CL, Lee CC, Hsu CH. The significance
of FDG uptake in bilateral thyroid glands. Nucl Med Commun.
2007 Feb;28(2):117-22.
8. Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis,
significance, and management. Endocrinol Metab Clin North Am. 2000
Mar;29(1):187-203.
9. Shie P, Cardarelli R, Sprawls K, Fulda KG, Taur A. Systematic review:
prevalence of malignant incidental thyroid nodules identified on fluorine-18
fluorodeoxyglucose positron emission tomography. Nucl Med Commun.
2009 Sep;30(9):742-8.
10. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins
DA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules
found incidentally on whole-body PET-CT. Nucl Med Commun. 2007
May;28(5):373-81.
11. Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET
detected thyroid incidentalomas: need for further investigation? Ann Surg
Oncol. 2007 Jan;14(1):239-47.
12. Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, et al. Focal
thyroid lesions incidentally identified by integrated 18F-FDG PET/CT:
Clinical significance and improved characterization. J Nucl Med. 2006
Apr;47(4):609-15.

Downloads

Published

03-04-2020

How to Cite

Sriprapaporn, J. ., Srisuwan, B. ., Uiprasertkul, M. ., Tuchinda, P. ., Thongpraparn, T. ., & Hannanthawiwat, C. . (2020). Thyroid Cancer Presenting as an Incidentaloma Detected on F-18 FDG PET/CT Imaging: A Case Report. Siriraj Medical Journal, 63(6), 207–209. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/241538

Issue

Vol. 63 No. 6 (2011): November-December

Section

Case Report

License

Authors who publish with this journal agree to the following conditions:

Copyright Transfer

In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.

License

 Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.

Sharing and Access

Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.